DFPG Investments’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,700
Closed -$728K 194
2021
Q2
$728K Sell
24,700
-2,515
-9% -$49.4K 0.28% 89
2021
Q1
$458K Buy
+27,215
New +$620K 0.2% 101
2020
Q4
Sell
-50,000
Closed -$730K 194
2020
Q3
$730K Buy
+50,000
New +$771K 0.39% 74

DFPG Investments's TBIO Position: Q3 2021 in Review

DFPG Investments sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 24,700 shares — an estimated $728K sold.

DFPG Investments first reported a position in TBIO in Q3 2020 and held it in 3 quarters. The position peaked at $730K in Q3 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • DFPG Investments reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • DFPG Investments sold 24,700 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $728K.
  • DFPG Investments first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • DFPG Investments's Translate Bio, Inc. Common Stock position peaked at $730K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on DFPG Investments's 13F filing for Q3 2021, filed 19 Oct 2021.